INDUSTRY LEADERS

We've recruited thought leaders in the pharmaceutical and healthcare technology industries to lead the direction of ZappRx. Our team is made up of passionate entrepreneurs with expertise from leading companies such as Takeda, Walgreens, Google, Genzyme Corporation, and UnitedHealth Group. Their combined expertise helps us tackle the toughest problems in the specialty drug prescribing process, while building a purposeful company culture, rooted in improving our healthcare system.

EXECUTIVE TEAM


ZOË BARRY, FOUNDER & CEO

FOUNDER AND CEO

SANDY DICESARE

CHIEF OPERATING OFFICER

LORRIE CARR

CHIEF COMMERCIAL OFFICER

LIBBY CURTIS WEBB

SVP, PRODUCT

JAMES CORNICELLI

VP, CORPORATE STRATEGY

KAREN TIROZZI

VP, BUSINESS DEVELOPMENT

ZEESHAN KHAN

VP, PRODUCT

Rich Kramer

VP, COMMERCIAL OPERATIONS

BOARD OF DIRECTORS


PETER WIRTH

EXECUTIVE CHAIRMAN

JENS ECKSTEIN

PRESIDENT, SRONE

MARK MCDADE

MANAGING PARTNER, QIMING US HEALTHCARE FUND

KRISHNA YESHWANT

PARTNER, GV (BOARD OBSERVER)

JEREMY LEVIN

CEO AND CHAIRMAN, OVID THERAPEUTICS

JULIA AUSTIN

CTO, DIGITALOCEAN

JEFF BERKOWITZ

EXECUTIVE VICE PRESIDENT, UNITEDHEALTH GROUP

JEAN-FRANCOIS FORMELA

PARTNER, ATLAS VENTURE (BOARD OBSERVER)

ADVISORS


SIMON KENNEDY

SENIOR ADVISOR, BAIN & COMPANY

MIKE WYZGA

ADVISOR TO THE BOARD

JAY SILVERSTEIN

ADVISOR TO THE BOARD

SCOTT MCKAY

ADVISOR TO THE BOARD

Competitive analysis

    • How many prescriptions were written for my brand? Other brands? By whom?

    • How many prescriptions were filled? Refilled?

    • Am I missing fills from when patients change insurance?


Time to Fill (TTF)

    • How quickly are my scripts being filled?

    • What and where are the bottlenecks?

    • What are payers doing to impact access? Pricing?


Real-world evidence

    • When, how, and why does my drug work?

    • What patients, biomarkers, and companion diagnoses predict performance?

    • How many prescriptions were abandoned by patients? Why?